BCRX 经营现金流历史(2016–2025)
BIOCRYST PHARMACEUTICALS, INC. (BCRX) 年度经营现金流历史(来自 SEC 财报)—— 每个财年经营活动产生的现金净额。
$347.4MFY2025 · FY2016 以来:-$53.4M → $347.4M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $347.4M | +767.8% |
| FY2024 | -$52.0M | +45.3% |
| FY2023 | -$95.1M | +41.2% |
| FY2022 | -$161.8M | -13.9% |
| FY2021 | -$142.2M | -5.2% |
| FY2020 | -$135.1M | -50.8% |
| FY2019 | -$89.6M | +3.2% |
| FY2018 | -$92.6M | -125.0% |
| FY2017 | -$41.1M | +23.0% |
| FY2016 | -$53.4M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议